Atripla and Skin blushing/flushing - a phase IV clinical study of FDA data

Summary:

Skin blushing/flushing is reported as a side effect among people who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate), especially for people who are male, 50-59 old, also take Niaspan, and have Hiv test positive.

The phase IV clinical study analyzes which people have Skin blushing/flushing when taking Atripla. It is created by eHealthMe based on reports of 35,479 people who have side effects when taking Atripla from the FDA, and is updated regularly.

What is Atripla?

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 2,050 drugs and 2,919 conditions by eHealthMe. Check the latest studies of Skin blushing/flushing.

On Feb, 02, 2026

35,479 people reported to have side effects when taking Atripla.
Among them, 15 people (0.04%) have Skin blushing/flushing.

Could Atripla cause Skin blushing/flushing?

Among these 15 people:

What is the gender of people who have Skin blushing/flushing when taking Atripla? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Skin blushing/flushing when taking Atripla? *

What are other drugs people take besides Atripla? *

What are other side effects people have besides Skin blushing/flushing? *

Insomnia (sleeplessness): 5 people, 33.33%
Abnormal Dreams: 4 people, 26.67%
Osteoporosis (bones weak and more likely to break): 4 people, 26.67%
Depression: 4 people, 26.67%
Burning Sensation Mucosal: 4 people, 26.67%
Intervertebral Disc Degeneration (spinal disc degeneration): 4 people, 26.67%
Memory Loss: 4 people, 26.67%
Skin Discoloration: 4 people, 26.67%
Feeling Hot: 3 people, 20.00%
Poor Dental Condition: 2 people, 13.33%

What are the existing conditions these people have? *

Right Ventricular Failure (right half of the heart fails to work): 2 people, 13.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
Hiv Test Positive: 2 people, 13.33%
Pain: 1 person, 6.67%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 6.67%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.67%
High Density Lipoprotein Decreased: 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Gout (uric acid crystals building up in the body): 1 person, 6.67%
Erection Problems: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Atripla and have Skin blushing/flushing?

- Check whether Skin blushing/flushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atripla:

Atripla (36,036 reports)

Skin blushing/flushing treatments and more:

Skin blushing/flushing (117,675 reports)

How severe was Skin blushing/flushing and when was it recovered:

Skin blushing/flushing in Atripla

Expand to all the drugs that have ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate:

Skin blushing/flushing and drugs with ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate (16 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atripla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,050 drugs)

Browse all the conditions that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,919 conditions)

Drugs similar to Atripla and Skin blushing/flushing :

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Atripla) and Atripla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.